AMLX
Amylyx Pharmaceuticals Inc

2,158
Mkt Cap
$1.53B
Volume
1.57M
52W High
$17.49
52W Low
$3.11
PE Ratio
-8.89
AMLX Fundamentals
Price
$13.81
Prev Close
$14.05
Open
$14.13
50D MA
$14.34
Beta
1.71
Avg. Volume
831,734.41
EPS (Annual)
-$1.53
P/B
4.97
Rev/Employee
$0.00
$831.33
Loading...
Loading...

About

Amylyx Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of therapies for diseases with significant unmet medical need, with an emphasis on endocrine and neurodegenerative disorders. Its program, avexitide, is a once-daily GLP-1 receptor antagonist being developed for the treatment of post-bariatric hypoglycemia. Amylyx’s pipeline also includes investigational programs targeting Wolfram syndrome and amyotrophic lateral sclerosis (ALS). The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
136

Frequently Asked Questions

What is Market Cap of Amylyx Pharmaceuticals Inc?
What is the 52-week high for Amylyx Pharmaceuticals Inc?
What is the 52-week low for Amylyx Pharmaceuticals Inc?
What is Amylyx Pharmaceuticals Inc stock price today?
What was Amylyx Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Amylyx Pharmaceuticals Inc?
What is the Price-to-Book ratio of Amylyx Pharmaceuticals Inc?
What is the 50-day moving average of Amylyx Pharmaceuticals Inc?
How many employees does Amylyx Pharmaceuticals Inc have?

Latest AMLX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.